CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
prednisone in symptomatic bone-only metastatic castration-resistant prostate cancer (mCRPC)Open-label, randomized phase II trial in ...
Phase 2
Milano, Italy and 15 other locations
(PK), pharmacodynamics, and preliminary efficacy of multiple anti-cancer agents in participants with metastatic prostate cancer...
Phase 1, Phase 2
Milan, Italy and 36 other locations
The aim of this study is to assess the safety and dosimetry of imaging with \[68Ga\]Ga-OncoACP3 in patients with prostate cancer....
Phase 1
Bergamo, Bergamo, Italy and 1 other location
The main purpose of this study is to assess the safety and tolerability of AZD0516 as monotherapy and/or in combination with other anti-cancer...
Phase 1, Phase 2
Milan, Italy and 51 other locations
and abiraterone in patients with metastatic castration-resistant prostate cancer (mCRPC) who have received no prior cytotoxic chemo ...
Phase 3
Milan, Italy and 131 other locations
with high-risk and very high-risk localised/locally advanced prostate cancer with a breast cancer gene mutation (BRCAm)....
Phase 3
Milan, Italy and 345 other locations
The primary objective of this study is to compare overall survival (OS) in participants receiving xaluritamig plus abiraterone against investigator's...
Phase 3
Milan, Italy and 155 other locations
The purpose of this study is to collect long term safety data in subjects who are continuing to derive clinical benefit from treatment with Enzalutam...
Phase 2
Cremona, Italy and 233 other locations
This is a phase III, randomized, open-label, multi-center study to assess the efficacy of treatment intensification with docetaxel plus apalutamide a...
Phase 3
Milan, Italy and 55 other locations
efficacy of the two different treatment combinations of tulmimetostat in participants with de novo or recurrent Metastatic Hormone-Sensitive Prostate...
Phase 1, Phase 2
Rozzano, MI, Italy and 30 other locations
Clinical trials
Research sites
Resources
Legal